August 10, 2013
If you are looking to invest in listed pharma companies, it may be time to pay greater attention to companies with a strong presence in the domestic markets. With just a third of the Indian pop...
Mumbai, Aug. 9
Drug-maker Sun Pharma took a hit on its bottom-line for the three months ended June 2013, following its recent $550-million settlement with Wyeth on Protonix, used to treat gastrointestinal ulcers...
Mumbai, July 30
After Cipla, Sun Pharma has also received interim relief from the Delhi High Court in a case related to implementation of the Drug Price Control Order 2013. According to a legal source, the compan...
July 19, 2013
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of resolution passed by the shareholders by way of Postal Ballot on July 15, 2013.
Source : BSE - »
July 15, 2013
Sun Pharma (Hold)CMP: Rs 1,107.80Target: Rs 1,022Sun Pharma has announced the US FDA approval of much- awaited generic Prandin (Repaglin...
New Delhi, June 21
Sun Pharmaceutical Industries and Glenmark Generics have got approval from US health regulator to sell generic versions of nervous system disorder treatment drug Riluzole.As per the United...
Mumbai, June 13
Shares of Sun Pharmaceuticals fell nearly 7 per cent in early trade today, after the pharmaceutical major and Israel’s Teva agreed to pay $2.15 billion to Pfizer and Takeda as part of patent infri...
New Delhi, June 5
Swedish drug firm Meda AB, which has been reported to be in discussions with Sun Pharmaceutical Industries for a $5-billion stake sale, has denied that it is in talks with any potential buyer. »
BL Research Bureau
L&T, Sun Pharma declare bonus shares too
June 1, 2013
Cipla’s gross profit margin (standalone) improved in the March quarter but its operating margin declined 0.6 percentage points due to higher personnel costs and other expenses. Net profit declined...
August 10, 2013
Provision for damages payable to Wyeth for the launch of generic Protonix ahead of a legal settlement led Sun Pharma to report a loss of Rs 1,276 crore during the quarter. The payment is l...
July 31, 2013
Jayant Sanghvi has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Source : BSE - www.bseindia.com<...
New Delhi, July 19
Drug major Sun Pharma has recalled certain lots of Nimodine capsules, a drug indicated to treat brain haemorrhage, in the US market due to crystal formation.
As per the information availa...
July 19, 2013
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed Record Date as July 30, 2013 in order to determine the names of Members who are entitled to receive Bonus Equity shares...
New Delhi, July 12
Sun Pharmaceutical Industries has received final approval from the US health regulator for its generic Repaglinide tablets used for the treatment of diabetes.The company is eligible for a 1...
June 15, 2013
The market, which had been on a losing streak since Tuesday, reversed course on Friday. The benchmark indices, nonetheless, ended the week lower. Both the Sensex and the Nifty lost over 1.2 per cen...
New Delhi, Jun 12
Drug-maker Sun Pharma will fork out about Rs 3,190 crore ($550 million), as part of its settlement in the case involving pantoprazole, used to treat gastro-intestinal ulcers and hyperacidity. »
Coimbatore, June 4
Sun Pharmaceutical Industries Ltd has got final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for generic version of Depo-Testosterone Injection, Testosterone C...
New Delhi, June 2
Drug major Sun Pharmaceutical Industries is said to be in talks to buy Sweden’s pharma firm Meda AB in a deal worth up to $5 billion, according to media reports.Sun Pharma has been in talks...
May 29, 2013
Sun Pharma reported 32 per cent revenue growth for the March quarter aided by healthy growth in the US market. The integration of recent acquisitions and sales of products such as generic Doxil le...